Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Pharma
Eylea HD sales jump in Q3 but Regeneron still cedes market share
While sales of Regeneron's high-dose version of Eylea were up 29% sequentially, this didn't translate to a bump in Eylea franchise sales in the U.S.
Kevin Dunleavy
Oct 31, 2024 11:37am
Anyone with lungs can get cancer, warns new campaign
Oct 23, 2024 12:46pm
Roche CEO critiques Novo's proposed Catalent buyout
Oct 23, 2024 12:35pm
Roche's Vabysmo will rise above Eylea biosim threat, exec says
Oct 23, 2024 11:24am
AstraZeneca-CSPC, Astellas and more—Fierce Pharma Asia
Oct 11, 2024 9:48am
Roche burnishes breast cancer portfolio with FDA nod for Itovebi
Oct 10, 2024 5:30pm
